Bayer confident on meeting 1996 operating profit profit target
This article was originally published in Clinica
Executive Summary
Bayer, the German chemicals, healthcare and agriculture group, saw healthcare sales increase 4% to DM 8,676 million ($5,640 million) in the first nine months. The division includes Bayer's diagnostics business which generated 14% of healthcare sales last year. Corrected for divestments, such as the dental products business, healthcare sales grew 7% in the first nine months.